Merck
Search Within

313-04-2

Filtros aplicados
Palabra clave:'313-04-2'
Mostrando 1-2 of 2 resultados para "313-04-2" en el plazo de Papeles
Erich M Sturgis et al.
Archives of otolaryngology--head & neck surgery, 128(9), 1084-1088 (2002-09-11)
To determine the effect of the ERCC1 C8092A polymorphism and the ERCC2/XPD G23591A polymorphism on the risk of squamous cell carcinoma of the head and neck (SCCHN). A hospital-based case-control study. A total of 330 newly diagnosed case subjects with
Vincent Ribrag et al.
Blood, 113(14), 3307-3313 (2008-09-05)
Hodgkin lymphoma is a highly curable malignancy, but treatment outcome might be influenced by inherited gene polymorphisms determining anticancer agent metabolism. We prospectively collected peripheral blood lymphocytes from 313 patients with Hodgkin lymphomas to analyze GSTP1, GSTM1, GSTT1, UGT1A1, and
Página 1 de 1
Página 1 de 1